The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender

Corxel Pharmaceuticals has acquired an oral small molecule GLP-1 agonist with potential applications in obesity and diabetes. The Phase 2-ready pill could compete with oral metabolic meds in development by companies such as Roche, AstraZeneca, and Structure Therapeutics. The post The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender appeared first on…

Read More

Trump’s Order on Gender-Affirming Care Escalates Reversal of Trans Rights

President Donald Trump ratcheted up his administration’s reversal of transgender rights on Tuesday with an executive order that seeks to intervene in parents’ medical decisions by prohibiting government-funded insurance coverage of puberty blockers or surgery for people under 19. Trump’s order, titled “Protecting Children From Chemical and Surgical Mutilation,” is certain to face legal challenges…

Read More